Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumResearch in context

• Główni autorzy: Toni K. Choueiri (Autor), Chris Labaki (Autor), Ziad Bakouny (Autor), Chih-Yuan Hsu (Autor), Andrew L. Schmidt (Autor), Gilberto de Lima Lopes, Jr (Autor), Clara Hwang (Autor), Sunny R.K. Singh (Autor), Chinmay Jani (Autor), Lisa B. Weissmann (Autor), Elizabeth A. Griffiths (Autor), Susan Halabi (Autor), Ulysses Wu (Autor), Stephanie Berg (Autor), Timothy E. O'Connor (Autor), Trisha M. Wise-Draper (Autor), Orestis A. Panagiotou (Autor), Elizabeth J. Klein (Autor), Monika Joshi (Autor), Fares Yared (Autor), Miriam Santos Dutra (Autor), Na Tosha N. Gatson (Autor), Sibel Blau (Autor), Harpreet Singh (Autor), Rahul Nanchal (Autor), Rana R. McKay (Autor), Taylor K. Nonato (Autor), Ryann Quinn (Autor), Samuel M. Rubinstein (Autor), Matthew Puc (Autor), Blanche H. Mavromatis (Autor), Praveen Vikas (Autor), Bryan Faller (Autor), Howard A. Zaren (Autor), Salvatore Del Prete (Autor), Karen Russell (Autor), Daniel Y. Reuben (Autor), Melissa K. Accordino (Autor), Christopher R. Friese (Autor), Sanjay Mishra (Autor), Donna R. Rivera (Autor), Yu Shyr (Autor), Dimitrios Farmakiotis (Autor), Jeremy L. Warner (Autor)
• Format: Książka
• Wydane: Elsevier, 2023-03-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Summary: Background: Breakthrough SARS-CoV-2 infections following vaccination against COVID-19 are of international concern. Patients with cancer have been observed to have worse outcomes associated with COVID-19 during the pandemic. We sought to evaluate the clinical characteristics and outcomes of...